Retrophin Inc (NASDAQ:RTRX)

22.72
Delayed Data
As of 11:45am ET
 -0.02 / -0.09%
Today’s Change
7.85
Today|||52-Week Range
25.99
+85.62%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close22.74
Today’s open23.57
Day’s range21.25 - 24.29
Volume480,052
Average volume (3 months)563,236
Market cap$747.9M
Dividend yield--
Data as of 11:45am ET, 04/28/2015

Growth & Valuation

Earnings growth (last year)-86.13%
Earnings growth (this year)+73.39%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales10.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ANIPANI Pharmaceuticals ...+1.16+1.75%
IMGNImmunoGen Inc-0.25-2.82%
OVASOvaScience Inc-0.28-0.99%
BCRXBioCryst Pharmaceuti...-0.16-1.61%
Data as of 12:00pm ET, 04/28/2015

Financials

Next reporting dateMay 13, 2015
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$28.2M
Annual profit (last year)-$110.9M
Net profit margin-393.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stephen J. Aselage
Chief Financial Officer &
Senior Vice President
Laura M. Clague
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers